Clinical Trials and Research News Weekly Roundup | Dr. Tarek Alam’s Ivermectin Working |S2 E30

Jul 27, 2020 | Digital Media, Video, Weekly Roundup

TrialSite News Weekly Roundup
Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% With Between 400-500 Patients & More Research to Come: Dr. Tarek Alam, a highly respected physician and professor of Medicine at Bangladesh Medical College (BMC), used two economical and easily available drugs to treat patients suffering from COVID-19 with considerable success in not only reducing the patients’ viral load, but also cutting the severity of their cases. Dr. Alam, who kindly did an interview with TrialSite News, reports that 98% of his COVID-19 patients are cured by the combined use of anti-parasitic drug ivermectin and antibiotic Doxycycline within 4 to 14 days. As Dr. Alam reported to the TrialSite, he secured BMC approved protocol to use this combination to great success.…
Degrees Pharmaceuticals & Collaborative Team Declare Antiparasitic Tafenoquine Zaps Sars-Cov-2 in a Cell Culture:A small Washington, D.C.-based biotech firm called Sixty Degrees Pharmaceuticals (60P) in partnership with commercial labs, a drug development services company, and the Gates Foundation recently conducted a series of laboratory experiments with another antiparasitic drug targeting COVID-19. 60P is majority-owned by Geoffrey Dow, a former Walter Reed research scientist, who has filed for patents associating Tafenoquine (TQ) and the potential to inhibit SARS-CoV-2, the pathogen behind the COVID-19 pandemic. Tafenoquine is used to treat malaria much like Hydroxychloroquine as well as Plasmodium vivax. Now this group led by 60P has demonstrated that initial testing in cell culture evidences that tafenoquine (ARAKODA®) is active against SARS-CoV-2 at clinically relevant concentrations.…
May Help Prevent and Slow COVID-19:Interferons occur naturally in the body; when a cell is infected by a virus, these signaling proteins are released to bolster other cells’ defenses. Once expensive to make, they can now be mass produced using genetically-modified bacteria. While appearing in the headlines less than other drugs, interferon may have an important role in fighting COVID-19. On July 10, Science asked, “Can interferons stop COVID-19 before it takes hold?” Reporting a “huge void” in COVID-19 treatments, it is argued tha, “Doctors have no drugs that, given early, have been proven to prevent infection or help beat back the virus before it takes hold.” So far, only remdesivir and dexamethasone have been validated, but they only seem to work on hospitalized patients. New research suggests SARS-CoV-2 disables interferons. “If so, synthetic interferons given before or soon after infection may tame the virus before it causes serious disease—a welcome possibility that additional recent studies support.” Several interferons have been FDA approved for decades, and their use includes cancer and hepatitis. Notably, a preventative trial in Hubei, China resulted in zero infections among 2,415 medical workers who used “daily interferon nose drops,” according to “a medRxiv preprint.”…
Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences over the Evidence while Demand SoarsJUL 18, 2020 | ACTEMRA, CORONAVIRUS, COVID-19, IL-6 INHIBITORS, INDIA, ITOLIZUMAB, NEWS, POPULAR POSTS, PRICE WATCH, TOCILIZUMAB…
Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences over the Evidence while Demand SoarsRecently, India’s Central Drugs Standard Control Organization (CDSCO) approved Itolizumab for patients infected with COVID-19. Moreover, Tocilizumab’s use for COVID-19 is accepted off-label by the Indian regulator. Associated as costly and not easily procured drugs, the State of Assam in India is the first such state in that nation to procure Itolizumab just days after its approval. Hospital providers are administering aggressive treatments to keep patients from progressing into severe and critical states in a bid to reduce deaths. Certain more critical circles within India are concerned about how Itolizumab was rushed through to approval by regulators and the drug’s sponsor called Biocon Limited of Bangladesh. Balram Bhargava, the Director-General of the Indian Council of Medical Research (ICMR), frets there’s a lack of sufficient evidence from the clinical trials that these drugs reduce the death rate in COVID-19 patients.…


  1. Sheila

    There is a new spray being tested. Is there any further information
    This was created by a Miami doctor and has simple and cheap ingredients. Is there any other information available?

    • TrialSite

      Hello Sheila,
      This is the first we have heard of this. The link doesn’t go to the actual non-peer reviewed results but we will look into this.There is a surprising amount of experimentation going on by providers in the field. Of course none of it represents actual clinical evidence but nonetheless “real world” data can be important for more focused studies.
      Thanks for visiting the TrialSite! We are grateful.

  2. Rick Keizer MD

    Is anything going on with N-Acetyl Cysteine? Judging by it’s value with RSV and influenza prevention and treatment, I would have thought it one of the first drugs hit on for SARS-Cov2 treatment. (See DeFlora 1997 study on H1N1 for example).
    Since it is available OTC in USA, I’m not surprised it is ignored here. But I would think countries seeking low cost treatment would try it for either prevention or treatment or both.

    • ML

      Rick, the Med Cram guy, Dr. Roger Seheult who offers stellar Covid lectures for free several times a week on youtube, takes N-AC himself daily. So do I now. We used to use it in ICU for acetaminophen overdoses. It’s a great anti-oxidant, plus, it seems to break up the Von Willebrand “strands” that form in the endothelium, causing clots. What I found out pleasantly for myself, is that my allergies and mild asthma stopped bothering me entirely. Then I researched other uses for it and sure enough, it can help allergies and asthma. It certainly breaks up mucus strands. It helps neutralize superoxide radicals according to Dr. Seheult. Cheers.

Pin It on Pinterest